- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT05453565
패혈증의 혈역학 소생술을 위한 제한 또는 자유 수액 (FRESHLY)
저혈압 메타 분석(FRESHLY)을 통한 패혈증의 유체 제한 소생술: ARISE FLUIDS, CLASSIC, CLOVERS 및 EVIS 임상시험의 개별 환자 데이터 메타 분석
A prospective, individual patient data meta-analysis (IPDMA) of four multicentre, open-label, randomised clinical trials of initial haemodynamic resuscitation in patients with septic shock.
연구 개요
상세 설명
This study is a prospective, individual patient data meta-analysis (IPDMA) of four multicentre, open-label, randomised clinical trials of initial haemodynamic resuscitation in patients with septic shock.
The investigators will include four multicentre, open-label, randomised, clinical trials:
- Australasian Resuscitation in Sepsis Evaluation Fluids of Vasopressors in Emergency Department Sepsis (ARISE FLUIDS) trial conducted in Australia and New Zealand. ClinicalTrials.gov identifier NCT04569942
- Conservative versus Liberal Approach to fluid therapy of Septic Shock in intensive Care (CLASSIC) trial conducted in seven European countries. ClinicalTrials.gov identifier NCT03668236
- Crystalloid Liberal or Vasopressors Early (CLOVERS) trial conducted in the United States. ClinicalTrials.gov identifier NCT03434028
- Early Vasopressors in Sepsis (EVIS) trial conducted in the United Kingdom. ClinicalTrials.gov identifier NCT05179499
All four trials have all received relevant approval from a research ethics committee with a locally appropriate method of obtaining consent. These trials are prospectively chosen prior to the results of any individual trial being known because they are investigating the same broad question in patients with acute septic shock across several countries. The investigators of these trials collaborated to harmonise data and outcomes as far as possible across all trials to facilitate an IPDMA.
The aims to provide high level evidence to address the question of whether a fluid sparing/early vasopressor approach or a liberal fluid/later vasopressor approach to initial haemodynamic resuscitation in septic shock results in improved outcomes, including mortality.
연구 유형
등록 (추정된)
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
All trials include adult patients requiring resuscitation for hypotension or hypoperfusion due to suspected sepsis as defined in the original studies. Participants may be enrolled in the emergency department, acute care ward or intensive care unit.
설명
Inclusion Criteria:
Participants of the ARISE FLUIDS, CLASSIC, CLOVERS & EVIS trials who had:
- Suspected or proven infection
- Systolic blood pressure (SBP) <100 mm Hg OR mean arterial pressure (MAP) <65 mm Hg
- Lactate ≥ 2.0 mmol/L
- Requirement for vasopressors to meet perfusion targets
Exclusion criteria:
Participants not in the ARISE FLUIDS, CLASSIC, CLOVERS & EVIS trials
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: OTHER
- 시간 관점: OTHER
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
Vasopressors
A haemodynamic resuscitation strategy based upon the restriction of IV fluids (by either volume or rate of infusion) with initiation or change of rate of vasopressors if required to meet perfusion targets |
A haemodynamic resuscitation strategy based upon the restriction of IV fluids (by either volume or rate of infusion) with initiation or change of rate of vasopressors if required to meet perfusion targets |
|
Fluids
A strategy of resuscitation with intravenous fluids as the primary intervention to achieve perfusion targets with subsequent initiation or change of rate of vasopressors if required. |
A strategy of resuscitation with intravenous fluids as the primary intervention to achieve perfusion targets with subsequent initiation or change of rate of vasopressors if required. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
All-cause mortality at 90 days post randomisation
기간: 90 days
|
Death from any cause at 90 days after randomisation |
90 days
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Time from randomisation to death
기간: Up to day 90
|
Time from randomisation to death |
Up to day 90
|
|
Incidence of mechanical ventilation
기간: from randomisation until day 90 post-randomisation
|
Commencement of mechanical ventilation from randomisation until day 90 post-randomisation |
from randomisation until day 90 post-randomisation
|
|
Incidence of acute renal replacement therapy
기간: from randomisation until day 90 post-randomisation
|
Commencement of renal replacement therapy from randomisation until day 90 post-randomisation |
from randomisation until day 90 post-randomisation
|
|
Days alive free of organ support at 28 days post randomisation
기간: from randomisation until day 28 post-randomisation
|
days the patient is alive and receiving nil organ support from from randomisation until day 28 post-randomisation |
from randomisation until day 28 post-randomisation
|
|
Duration of hospital stay
기간: From randomisation until day 90 post-randomisation
|
Length of time in hospital from randomisation until death or hospital discharge or day 90 post-randomisation |
From randomisation until day 90 post-randomisation
|
|
Incidence of serious adverse events
기간: from randomisation until day 90 post-randomisation
|
Number of adverse events from randomisation until day 90 post-randomisation |
from randomisation until day 90 post-randomisation
|
|
Duration of intensive care unit (ICU) stay
기간: From randomisation until day 90 post-randomisation
|
Length of time in ICU from randomisation until death or hospital discharge or day 90 post-randomisation |
From randomisation until day 90 post-randomisation
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .